1. Home
  2. ATLN vs NKTX Comparison

ATLN vs NKTX Comparison

Compare ATLN & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLN
  • NKTX
  • Stock Information
  • Founded
  • ATLN 2014
  • NKTX 2015
  • Country
  • ATLN United States
  • NKTX United States
  • Employees
  • ATLN N/A
  • NKTX N/A
  • Industry
  • ATLN
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATLN
  • NKTX Health Care
  • Exchange
  • ATLN NYSE
  • NKTX Nasdaq
  • Market Cap
  • ATLN 140.1M
  • NKTX 123.5M
  • IPO Year
  • ATLN 2021
  • NKTX 2020
  • Fundamental
  • Price
  • ATLN $2.19
  • NKTX $1.84
  • Analyst Decision
  • ATLN
  • NKTX Strong Buy
  • Analyst Count
  • ATLN 0
  • NKTX 6
  • Target Price
  • ATLN N/A
  • NKTX $14.40
  • AVG Volume (30 Days)
  • ATLN 70.3K
  • NKTX 464.6K
  • Earning Date
  • ATLN 08-22-2025
  • NKTX 08-12-2025
  • Dividend Yield
  • ATLN N/A
  • NKTX N/A
  • EPS Growth
  • ATLN N/A
  • NKTX N/A
  • EPS
  • ATLN N/A
  • NKTX N/A
  • Revenue
  • ATLN $444,795,409.00
  • NKTX N/A
  • Revenue This Year
  • ATLN N/A
  • NKTX N/A
  • Revenue Next Year
  • ATLN N/A
  • NKTX N/A
  • P/E Ratio
  • ATLN N/A
  • NKTX N/A
  • Revenue Growth
  • ATLN 10.11
  • NKTX N/A
  • 52 Week Low
  • ATLN $1.68
  • NKTX $1.31
  • 52 Week High
  • ATLN $7.97
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • ATLN N/A
  • NKTX 53.65
  • Support Level
  • ATLN N/A
  • NKTX $1.74
  • Resistance Level
  • ATLN N/A
  • NKTX $1.90
  • Average True Range (ATR)
  • ATLN 0.00
  • NKTX 0.08
  • MACD
  • ATLN 0.00
  • NKTX 0.02
  • Stochastic Oscillator
  • ATLN 0.00
  • NKTX 77.78

About ATLN ATLANTIC INTERNATIONAL CORP

Atlantic International Corp is a U.S.-based outsourced services and workforce solutions company. The company specializes in permanent, temporary, and temporary-to-permanent placement services in various areas, including accounting and finance, administrative and clerical, hospitality, information technology, legal, light industrial, and medical fields. It also provides productivity consulting and workforce management solutions.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: